| Mayor Group, Llc | |
|
311 S Livingston Ave Livingston NJ 07039-3927 | |
| (973) 994-0221 | |
| Not Available |
| Full Name | Mayor Group, Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 311 S Livingston Ave, Livingston, New Jersey |
| Authorized Official Name and Position | Gilbert Mayor (OWNER) |
| Authorized Official Contact | 9739987993 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mayor Group, Llc Po Box 303 Mount Freedom NJ 07970-0303 Ph: (973) 998-7993 | Mayor Group, Llc 311 S Livingston Ave Livingston NJ 07039-3927 Ph: (973) 994-0221 |
| NPI Number | 1154618874 |
|---|---|
| Provider Enumeration Date | 07/01/2011 |
| Last Update Date | 07/01/2011 |
| Medicare PECOS PAC ID | 4082884259 |
|---|---|
| Medicare Enrollment ID | O20110825000170 |
News Archive
There is an enormous amount of interest in using meditation as a form of therapy to cope with a variety of modern-day health problems, especially hypertension, stress and chronic pain, but the majority of evidence that seems to support this notion is anecdotal, or it comes from poor quality studies, say Maria Ospina and Kenneth Bond, researchers at the University of Alberta/Capital Health Evidence-based Practice Center in Edmonton, Canada.
The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).
The National Necrotizing Fasciitis Foundation today announced that it has awarded NNFF's Lifetime Health-Science Achievement Award 2015 to John Crew, MD and Ron Najafi, PhD for "Excellence in Innovative Healthcare". Their pioneering work has improved care for patients with life-threatening 'flesh-eating' disease and other types of wounds.
InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).
Australian adult stem cell company, Mesoblast Limited, today announced that its chief scientific advisor and founder, Professor Silviu Itescu, has been awarded a $1.5 million grant for pre-clinical and clinical development of mesenchymal lineage adult stem cells.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154618874 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA06640100 (New Jersey) | Primary |
| Provider Name | Jacquelin Holubka |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1174577373 PECOS PAC ID: 9638070147 Enrollment ID: I20040420000973 |
News Archive
There is an enormous amount of interest in using meditation as a form of therapy to cope with a variety of modern-day health problems, especially hypertension, stress and chronic pain, but the majority of evidence that seems to support this notion is anecdotal, or it comes from poor quality studies, say Maria Ospina and Kenneth Bond, researchers at the University of Alberta/Capital Health Evidence-based Practice Center in Edmonton, Canada.
The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).
The National Necrotizing Fasciitis Foundation today announced that it has awarded NNFF's Lifetime Health-Science Achievement Award 2015 to John Crew, MD and Ron Najafi, PhD for "Excellence in Innovative Healthcare". Their pioneering work has improved care for patients with life-threatening 'flesh-eating' disease and other types of wounds.
InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).
Australian adult stem cell company, Mesoblast Limited, today announced that its chief scientific advisor and founder, Professor Silviu Itescu, has been awarded a $1.5 million grant for pre-clinical and clinical development of mesenchymal lineage adult stem cells.
› Verified 8 days ago
News Archive
There is an enormous amount of interest in using meditation as a form of therapy to cope with a variety of modern-day health problems, especially hypertension, stress and chronic pain, but the majority of evidence that seems to support this notion is anecdotal, or it comes from poor quality studies, say Maria Ospina and Kenneth Bond, researchers at the University of Alberta/Capital Health Evidence-based Practice Center in Edmonton, Canada.
The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).
The National Necrotizing Fasciitis Foundation today announced that it has awarded NNFF's Lifetime Health-Science Achievement Award 2015 to John Crew, MD and Ron Najafi, PhD for "Excellence in Innovative Healthcare". Their pioneering work has improved care for patients with life-threatening 'flesh-eating' disease and other types of wounds.
InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).
Australian adult stem cell company, Mesoblast Limited, today announced that its chief scientific advisor and founder, Professor Silviu Itescu, has been awarded a $1.5 million grant for pre-clinical and clinical development of mesenchymal lineage adult stem cells.
› Verified 8 days ago
Integrative Health And Wellness, Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 S Orange Ave, Livingston, NJ 07039 Phone: 973-322-7007 Fax: 973-322-7528 | |
Heme Med Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 22 Old Short Hills Rd, Suite 108, Livingston, NJ 07039 Phone: 973-533-9299 Fax: 973-992-7648 | |
Essex Medical Center Md Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 22 Old Short Hills Rd, Suite #108, Livingston, NJ 07039 Phone: 973-535-5227 Fax: 973-535-3406 | |
Luigina Vlad, M.d., L.l.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 65 E Northfield Rd, Suite E, Livingston, NJ 07039 Phone: 973-422-9400 Fax: 973-422-9495 | |
Saude Medical Services, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 28 Wilson Ter, Livingston, NJ 07039 Phone: 973-535-5279 | |
The Endocrine Doctor Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 315 E Northfield Rd, Suite 1c, Livingston, NJ 07039 Phone: 973-992-1118 Fax: 973-992-3050 |